Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person.

BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...

At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...

Cystic fibrosis (CF) caused by a gene that doesn’t work properly. Learn what genetic testing can tell you about this faulty gene, and what your next steps may be.

Cystic fibrosis is a hereditary disease caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR gene encodes an ion channel protein that is involved in ...

A new set of standardized screening recommendations from the Cystic Fibrosis Foundation aims to reduce missed or delayed diagnosis of the genetic disorder among infants. All 50 U.S. states screen ...

How is cystic fibrosis diagnosed? Genetic testing may detect gene mutations in cystic fibrosis. People can get a blood test to determine whether they are carriers.

The report of one of these bodies, the ACMG Subcommittee on Cystic Fibrosis Screening, appears in this issue of Genetics in Medicine. 21 It represents the end result of many hours of deliberation ...